What new STI prevention findings mean for SA

Last year, Spotlight reported that taking a widely available antibiotic, doxycycline after condomless sex can reduce the risk of contracting three different sexually transmitted infections (STIs). Elri Voigt unpacks some further results from three studies presented at CROI2023 on Doxycycline as post-exposure prophylaxis (PEP) for STI prevention.

Read More

An open letter to us girls who still shoulder much of the HIV burden in South Africa

In an open letter to young women in South Africa, Faith Fikizolo reminds us that meaningful comprehensive sex education is an important lever in ensuring girls and young women are fully empowered to exercise their sexual and reproductive health rights. She argues that, due to the lack of meaningful sexuality education, many South African young women and girls lack bodily autonomy.

Read More

Face to Face: Prof Helen Rees on SAHPRA, women’s rights, and her appetite for justice

As a rebellious teenager growing up in the British town of Harpenden, Professor Helen Rees would sneak out to attend anti-apartheid talks. Today, she is a renowned scientist and chair of South Africa’s medicines regulator. Biénne Huisman chatted to Rees about her career, prioritising women’s reproductive health, and her role at the South African Health Products Regulatory Authority.

Read More

In-depth: Major SAMRC study sheds light on causes of disease and death in SA

Unsafe sex, interpersonal violence, high body mass index, high systolic blood pressure, and alcohol consumption are the top risk factors for disease and death in South Africa, according to the Second Comparative Risk Assessment study conducted by the South African Medical Research Council’s Burden of Disease Research Unit. Nthusang Lefafa spoke to some of the researchers to unpack the findings.

Read More

Opinion: Engaging communities and young people in the HIV response

The AIDS2022 conference held recently in Montreal, Canada highlighted yet again the need for community activism and the importance of involving young people, writes Dr Yogan Pillay. He argues that the youth and communities must be engaged in the conceptualisation and writing of South Africa’s new AIDS plan, and young people and community-based organisations must have a central role in key aspects of its implementation.

Read More

Are youth-only clinics the answer to better healthcare for young people?

Special youth clinics appear to be an effective means of providing healthcare services to young people who otherwise might not engage with healthcare services. But is building more youth clinics realistic given our resource constraints, or is it better to focus on making ‘normal’ clinics more youth-friendly – or should we be looking beyond clinic-based healthcare services altogether? Tiyese Jeranji investigates.

Read More

In-depth: What contraceptives are available in SA and which ones are most popular?

There are a variety of tools available today to prevent pregnancy including pills, intrauterine devices, subdermal implants, injections, condoms, male and female sterilisation, and emergency contraception. Statistics suggest that people in South Africa do, in principle at least, have access to and are aware of these contraceptive methods, albeit not at the desired levels. Elna Schütz looks at what contraceptive methods are available and makes some surprising discoveries along the way about which ones are most popular.

Read More

HPV: What is happening with SA’s other relatively new vaccine programme?

In 2014, South Africa launched an HPV vaccination campaign targeting 9-year-old public school learners in Grade 4. It involves delivering two doses of vaccine six months apart. Laura Owings asks how the campaign is going and what recent real-world HPV vaccine effectiveness data from the United Kingdom might mean for South Africa.

Read More

In-depth: What we know about SA’s rampant gonorrhoea epidemic

Despite the global emergence of highly resistant strains of gonorrhoea, including untreatable variants, a new antibiotic for the disease has not been developed in over half a century. In January, a trial began in South Africa and other countries for a new gonorrhoea antibiotic. But what is gonorrhoea? How significant is the problem in South Africa and among those living with HIV? Do we have resistant strains too? Experts report a grim situation, but with hope on the horizon. Amy Green reports.

Read More